person

Fabio S.

Country
Italy
Department
Azienda Ospedaliera di Padova - U.O.C. di Gastroenterologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
1
Sites with multiple studies

Has run more than one trial at 1 of 11 partner sites.

Specializations

Psychiatric Medicine

This investigator specializes in Major Depressive Disorder (MDD) treatment and research, with particular emphasis on developing enhanced therapeutic approaches for patients with inadequate response to conventional treatments.

  • Treatment-resistant depression
  • Adjunctive therapy development
  • Antidepressant enhancement strategies

Their research focuses on evaluating novel therapeutic interventions for depression using standardized assessment tools like the Montgomery-Åsberg Depression Rating Scale (MADRS).

Clinical Assessment

The investigator employs sophisticated clinical measurement methodologies to evaluate therapeutic responses in psychiatric conditions, particularly focusing on rapid-onset interventions for major depression.

  • Depression rating scales
  • Treatment response assessment
  • Short-term therapeutic outcomes

Their expertise includes evaluating both short-term and extended duration therapeutic responses in psychiatric conditions.

Therapeutic Innovation

The investigator explores novel therapeutic compounds and their potential as adjunctive treatments in major depression, with particular interest in enhancing the effectiveness of standard antidepressant therapies.

  • Combination therapy approaches
  • Novel therapeutic agents
  • Treatment augmentation strategies

Their work encompasses the evaluation of innovative therapeutic approaches for improving treatment outcomes in depression.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.